|
|
|
|
LEADER |
02905nam a2200373Ia 4500 |
001 |
10.11613-BM.2022.020704 |
008 |
220510s2022 CNT 000 0 und d |
020 |
|
|
|a 18467482 (ISSN)
|
245 |
1 |
0 |
|a Subfatin concentration decreases in acute coronary syndrome
|
260 |
|
0 |
|b NLM (Medline)
|c 2022
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.11613/BM.2022.020704
|
520 |
3 |
|
|a Introduction: We investigated the association of serum subfatin concentration and acute myocardial infarction (AMI) in patients with ST-elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI). Materials and methods: In this study, patients who presented with chest pain (STEMI, NSTEMI, or non-cardiac chest pain) were included, i.e. 49 patients with non-cardiac chest pain (control) and 66 patients hospitalised with AMI. In the AMI group, 35 patients had NSTEMI and 31 had STEMI. Serum subfatin concentrations were determined via enzyme-linked immunosorbent assay (ELISA). Descriptive data on the patients and their comorbidities were recorded, and subfatin concentrations were analysed. Results: Subfatin concentrations were significantly different in the control, STEMI and NSTEMI groups (P = 0.002). In addition, subfatin concentrations were significantly lower in patients in the NSTEMI group than those in the control group (P < 0.001), but there was no significant difference between STEMI and the control group (P = 0.143). The receiver operating characteristic (ROC) analysis performed for differentiating the AMI and control groups found that subfatin had 64% sensitivity and 69% specificity, whereas troponin had 59% sensitivity and 95% specificity. In patients with AMI, the ROC analysis for differentiating NSTEMI from STEMI found that subfatin had 94% sensitivity and 41% specificity, while troponin had 65% sensitivity and 88% specificity. Conclusions: Subfatin concentrations were lower in patients without STEMI than in patients with STEMI. Subfatin concentration is associated with NSTEMI. Croatian Society of Medical Biochemistry and Laboratory Medicine.
|
650 |
0 |
4 |
|a acute coronary syndrome
|
650 |
0 |
4 |
|a Acute Coronary Syndrome
|
650 |
0 |
4 |
|a acute myocardial infarction
|
650 |
0 |
4 |
|a Chest Pain
|
650 |
0 |
4 |
|a heart infarction
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a Humans
|
650 |
0 |
4 |
|a Myocardial Infarction
|
650 |
0 |
4 |
|a non ST segment elevation myocardial infarction
|
650 |
0 |
4 |
|a Non-ST Elevated Myocardial Infarction
|
650 |
0 |
4 |
|a non-ST-elevation myocardial infarction (NSTEMI)
|
650 |
0 |
4 |
|a ST Elevation Myocardial Infarction
|
650 |
0 |
4 |
|a ST segment elevation myocardial infarction
|
650 |
0 |
4 |
|a ST-elevation myocardial infarction (STEMI)
|
650 |
0 |
4 |
|a subfatin
|
650 |
0 |
4 |
|a thorax pain
|
650 |
0 |
4 |
|a troponin
|
650 |
0 |
4 |
|a Troponin
|
700 |
1 |
|
|a Cagri Goktekin, M.
|e author
|
700 |
1 |
|
|a Ilhan, N.
|e author
|
700 |
1 |
|
|a Yilmaz, M.
|e author
|
773 |
|
|
|t Biochemia medica
|